On Nov. 21, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding $29.7 million to…
On Nov. 15, 2024, researchers from Queen Mary University of London and the the University of Hong Kong…
On Nov. 15, 2024, an international research team including scientists from the Max Planck Institute reported that critical…
On Oct. 24, 2024, researchers from Children’s Medical Center Research Institute at UT Southwestern reported that ancient viral remnants…
On Sept. 26, 2024, a team of scientists in Peking University in Beijing, China announced that a 25-year-old…
On Jul. 25, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
On Apr. 26, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had approved awarding nearly $31…
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM) announced awards that support 11 projects in…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Dec. 8, 2023, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing…
On Nov. 16, 2023, Vertex and CRISPR Therapeutics announced that the United Kingdom (U.K.) Medicines and Healthcare products…
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
On Sept. 29, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $43.8 million to fund projects aimed…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
On Mar. 27, 2023, CIRM Board approved investing nearly $26 million in 17 projects in early-stage discovery research.The…
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
On Dec. 22, 2022, resarchers at the National Institutes of Health announced they had used patient stem cells…
On Nov. 7, 2022, the NHS Blood and Transplant (NHSBT) reported that red blood cells grown in a…
On Jul. 27, 2022, City of Hope announced that a 66-year-old man who was diagnosed with HIV in…
On Feb. 15, 2022, a woman with HIV who received a cord blood stem cell transplant to treat…
On May 20, 2021, Sorrento Therapeutics announced receipt of clearance from the Brazilian regulatory agency (ANVISA) to proceed…
On Mar. 1, 2021, a study from Washington University School of Medicine in St. Louis provided evidence that…
On Feb. 10, 2021, Notch Therapeutics closed $85 Million Series A financing to develop pipeline of renewable stem…
On Jan. 31, 2021, Sorrento Therapeutics announced additional positive results from its Phase 1b study of human allogeneic…
On Jan. 26, 2021, Sorrento Therapeutics announced positive preliminary results from its Phase 1b study of human allogeneic…
On Dec. 3, 2020, a team led by UT Southwestern announced that it had derived a new ﾓintermediateï¾”…
On Aug. 10, 2020, CBRï¾® by Generate Life Sciences, the worldï¾’s largest private newborn stem cell bank, and…
On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…